The pharmaceutical landscape is experiencing a change with the arrival of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to delivering glucagon-like peptide-1 https://laylahhnx301913.spintheblog.com/41272944/glp-1-patches-a-new-way-to-treat-diabetes